AM-3101

N/A

Report date: 2022/11/07 18:40:42
NME

Base Information

Drug NameAM-3101
Drug Alias NameAM-3101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsMeniscus InjuriesCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CincinnatiUnited States Department Of Defense
China Registration ClassN/A

Develop Information

Active CompaniesUnited States Department Of DefenseUniversity Of Cincinnati
Inactive CompaniesN/A
Active IndicationsMeniscus InjuriesCartilage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A